FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W200415659> ?p ?o ?g. }

• W200415659 endingPage "1232" @default.
• W200415659 startingPage "1225" @default.
• W200415659 abstract "Abstract Factor IX is a multidomain protein and is the proenzyme of a serine protease, factor IXa, essential for hemostasis. In this report, we describe the molecular basis of hemophilia B (deficiency of factor IX activity) in five patients who have neither deletions nor rearrangements of the factor IX gene. By enzymatic amplification and sequencing of all exons and promoter regions, the following causative mutation in the protease domain of factor IX was identified in each patient: IXSchmallenberg: nucleotide 31,215G----T, Ser365Ile; IXVarel: nucleotide 31,214A----G, Ser365Gly; IXMechtal: nucleotide 31,211G----C, Asp364His; IXDreihacken: nucleotide 30,864G----A, Arg248Gln; and IXMonschau: nucleotide 30,855A----T, Glu245Val. In IXVarel, nucleotide 31,213T was also replaced by C, which results in a silent mutation (GAT- ---GAC) at Asp-364. Thus, this patient has a double base-pair substitution of TA to CG at nucleotides 31,213 and 31,214 but only a single amino acid change of Ser-365 to Gly. This patient also developed an antibody to factor IX during replacement therapy, which suggests that deletion of the factor IX gene is not necessary for development of the antibody in hemophilia B patients. The levels of plasma factor IX antigen in the patients ranged from 40% to 100% except for IXDreihacken (Arg248Gln), in which case it was approximately 4% of normal. The Ser365Gly and Ser365Ile mutants are nonfunctional because of lack of the active site serine residue. Mutant Asp364His is inactive because it cannot form the hydrogen bond between the carboxylate group of Asp-364 and the alpha-amino group of Val-181 generated after activation. As observed in other homologous serine proteases, this hydrogen bond is essential for maintaining the correct active site conformation in normal factor IXa (IXaN). Purified Arg248Gln had approximately 41% and Glu245Val had approximately 17% of the activity of normal factor IX (IXN) in a partial thromboplastin time (aPTT) assay. In immunodot blot experiments, the isolated Glu245Val mutant did and the Arg248Gln mutant did not bind to an anti-IXN monoclonal antibody that has been shown previously to inhibit the interaction of factor VIIIa with factor IXaN. We have recently shown that a high-affinity calcium binding site exists in the protease domain of IXN; among the proposed Ca(2+)-binding ligands is the carboxyl group of Glu-245. Further, a part of the epitope for the above antibody was shown to be contained in the 231 to 265 residue segment of factor IX.(ABSTRACT TRUNCATED AT 400 WORDS)." @default.
• W200415659 created "2016-06-24" @default.
• W200415659 creator A5011861465 @default.
• W200415659 creator A5011885695 @default.
• W200415659 creator A5039838472 @default.
• W200415659 creator A5050285793 @default.
• W200415659 creator A5055080602 @default.
• W200415659 creator A5064068211 @default.
• W200415659 creator A5066642788 @default.
• W200415659 date "1992-03-01" @default.
• W200415659 modified "2023-09-30" @default.
• W200415659 title "Hemophilia B caused by five different nondeletion mutations in the protease domain of factor IX" @default.
• W200415659 cites W109650587 @default.
• W200415659 cites W137168614 @default.
• W200415659 cites W1502744283 @default.
• W200415659 cites W1566324809 @default.
• W200415659 cites W1602072399 @default.
• W200415659 cites W1604149400 @default.
• W200415659 cites W1671460938 @default.
• W200415659 cites W188447547 @default.
• W200415659 cites W1966136309 @default.
• W200415659 cites W1966875441 @default.
• W200415659 cites W1971513339 @default.
• W200415659 cites W1971784860 @default.
• W200415659 cites W1973388870 @default.
• W200415659 cites W1976418095 @default.
• W200415659 cites W1992497111 @default.
• W200415659 cites W1993390869 @default.
• W200415659 cites W1994013215 @default.
• W200415659 cites W2000835937 @default.
• W200415659 cites W2027744000 @default.
• W200415659 cites W2040089477 @default.
• W200415659 cites W2041349540 @default.
• W200415659 cites W2042648647 @default.
• W200415659 cites W2051462955 @default.
• W200415659 cites W2062617470 @default.
• W200415659 cites W2068793497 @default.
• W200415659 cites W2084591437 @default.
• W200415659 cites W2091748192 @default.
• W200415659 cites W2097803943 @default.
• W200415659 cites W2100837269 @default.
• W200415659 cites W2121486050 @default.
• W200415659 cites W2288564811 @default.
• W200415659 cites W2295080980 @default.
• W200415659 cites W2413795332 @default.
• W200415659 cites W2472426052 @default.
• W200415659 cites W2951807226 @default.
• W200415659 cites W62994428 @default.
• W200415659 cites W205962732 @default.
• W200415659 cites W2114708543 @default.
• W200415659 doi "https://doi.org/10.1182/blood.v79.5.1225.1225" @default.
• W200415659 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1346975" @default.
• W200415659 hasPublicationYear "1992" @default.
• W200415659 type Work @default.
• W200415659 sameAs 200415659 @default.
• W200415659 citedByCount "19" @default.
• W200415659 countsByYear W2004156592012 @default.
• W200415659 countsByYear W2004156592018 @default.
• W200415659 countsByYear W2004156592019 @default.
• W200415659 countsByYear W2004156592023 @default.
• W200415659 crossrefType "journal-article" @default.
• W200415659 hasAuthorship W200415659A5011861465 @default.
• W200415659 hasAuthorship W200415659A5011885695 @default.
• W200415659 hasAuthorship W200415659A5039838472 @default.
• W200415659 hasAuthorship W200415659A5050285793 @default.
• W200415659 hasAuthorship W200415659A5055080602 @default.
• W200415659 hasAuthorship W200415659A5064068211 @default.
• W200415659 hasAuthorship W200415659A5066642788 @default.
• W200415659 hasBestOaLocation W2004156591 @default.
• W200415659 hasConcept C104317684 @default.
• W200415659 hasConcept C143065580 @default.
• W200415659 hasConcept C153911025 @default.
• W200415659 hasConcept C181199279 @default.
• W200415659 hasConcept C185592680 @default.
• W200415659 hasConcept C203014093 @default.
• W200415659 hasConcept C2776414213 @default.
• W200415659 hasConcept C2776714187 @default.
• W200415659 hasConcept C2777292125 @default.
• W200415659 hasConcept C2777444498 @default.
• W200415659 hasConcept C2777807008 @default.
• W200415659 hasConcept C2781221834 @default.
• W200415659 hasConcept C2910886357 @default.
• W200415659 hasConcept C501734568 @default.
• W200415659 hasConcept C512185932 @default.
• W200415659 hasConcept C55493867 @default.
• W200415659 hasConcept C86803240 @default.
• W200415659 hasConcept C89560881 @default.
• W200415659 hasConceptScore W200415659C104317684 @default.
• W200415659 hasConceptScore W200415659C143065580 @default.
• W200415659 hasConceptScore W200415659C153911025 @default.
• W200415659 hasConceptScore W200415659C181199279 @default.
• W200415659 hasConceptScore W200415659C185592680 @default.
• W200415659 hasConceptScore W200415659C203014093 @default.
• W200415659 hasConceptScore W200415659C2776414213 @default.
• W200415659 hasConceptScore W200415659C2776714187 @default.
• W200415659 hasConceptScore W200415659C2777292125 @default.
• W200415659 hasConceptScore W200415659C2777444498 @default.
• W200415659 hasConceptScore W200415659C2777807008 @default.

• next